These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30130472)

  • 1. The Texture of Psychoactive Illicit Drugs in Iran: Adulteration with Lead and other Active Pharmaceutical Ingredients.
    Akhgari M; Moradi F; Ziarati P
    J Psychoactive Drugs; 2018; 50(5):451-459. PubMed ID: 30130472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adulteration Practices of Psychoactive Illicit Drugs: An Updated Review.
    Solimini R; Rotolo MC; Pellegrini M; Minutillo A; Pacifici R; Busardò FP; Zaami S
    Curr Pharm Biotechnol; 2017; 18(7):524-530. PubMed ID: 28699480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the risks associated with the use of new psychoactive substances (NPS): high variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products.
    Zamengo L; Frison G; Bettin C; Sciarrone R
    Toxicol Lett; 2014 Aug; 229(1):220-8. PubMed ID: 24910986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shifts in Unintentional Exposure to Drugs Among People Who Use Ecstasy in the Electronic Dance Music Scene, 2016-2019.
    Palamar JJ; Salomone A
    Am J Addict; 2021 Jan; 30(1):49-54. PubMed ID: 32813326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?
    Giné CV; Espinosa IF; Vilamala MV
    Drug Test Anal; 2014; 6(7-8):819-24. PubMed ID: 24470121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2C-B: a new psychoactive phenylethylamine recently discovered in Ecstasy tablets sold on the Swiss black market.
    Giroud C; Augsburger M; Rivier L; Mangin P; Sadeghipour F; Varesio E; Veuthey JL; Kamalaprija P
    J Anal Toxicol; 1998 Sep; 22(5):345-54. PubMed ID: 9737327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The variability of ecstasy tablets composition in Brazil.
    Togni LR; Lanaro R; Resende RR; Costa JL
    J Forensic Sci; 2015 Jan; 60(1):147-51. PubMed ID: 25125149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018.
    Al-Matrouk A; Al-Hasan M; Naqi H; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H
    BMC Public Health; 2021 Apr; 21(1):671. PubMed ID: 33827491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.
    Brunt TM; Nagy C; Bücheli A; Martins D; Ugarte M; Beduwe C; Ventura Vilamala M
    Drug Test Anal; 2017 Feb; 9(2):188-198. PubMed ID: 26888408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran.
    Nikfarjam A; Shokoohi M; Shahesmaeili A; Haghdoost AA; Baneshi MR; Haji-Maghsoudi S; Rastegari A; Nasehi AA; Memaryan N; Tarjoman T
    Int J Drug Policy; 2016 May; 31():147-52. PubMed ID: 26980349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principal component analysis of synthetic adulterants in herbal supplements advertised as weight loss drugs.
    Dastjerdi AG; Akhgari M; Kamali A; Mousavi Z
    Complement Ther Clin Pract; 2018 May; 31():236-241. PubMed ID: 29705461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystals and tablets in the Spanish ecstasy market 2000-2014: Are they the same or different in terms of purity and adulteration?
    Vidal Giné C; Ventura Vilamala M; Fornís Espinosa I; Gil Lladanosa C; Calzada Álvarez N; Fitó Fruitós A; Rodríguez Rodríguez J; Domíngo Salvany A; de la Torre Fornell R
    Forensic Sci Int; 2016 Jun; 263():164-168. PubMed ID: 27129144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roadside survey on alcohol and drug use among drivers in the Arctic county of Finnmark (Norway).
    Jamt REG; Gjerde H; Normann PT; Bogstrand ST
    Traffic Inj Prev; 2017 Oct; 18(7):681-687. PubMed ID: 28112544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of synthetic pharmaceutical adulterants in herbal weight gain supplements sold in herb shops, Tehran, Iran.
    Saberi N; Akhgari M; Bahmanabadi L; Bazmi E; Mousavi Z
    Daru; 2018 Dec; 26(2):117-127. PubMed ID: 30242673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-drug cocktails: Impurities in commonly used illicit drugs seized by police in Queensland, Australia.
    Peck Y; Clough AR; Culshaw PN; Liddell MJ
    Drug Alcohol Depend; 2019 Aug; 201():49-57. PubMed ID: 31181437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of presumptive color tests for new psychoactive substances.
    Cuypers E; Bonneure AJ; Tytgat J
    Drug Test Anal; 2016 Jan; 8(1):136-40. PubMed ID: 26333168
    [No Abstract]   [Full Text] [Related]  

  • 17. Chromatography as Method for Analytical Confirmation of Paracetamol in Postmortem Material Together with Psychoactive Substances.
    Biscevic-Tokic J; Tokic N; Ibrahimpasic E
    Acta Inform Med; 2015 Oct; 23(5):322-5. PubMed ID: 26635443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Quantification of Cocaine and Active Adulterants in Coca-Paste Seized Samples: Useful Scientific Support to Health Care.
    Abin-Carriquiry JA; Martínez-Busi M; Galvalisi M; Minteguiaga M; Prieto JP; Scorza MC
    Neurotox Res; 2018 Aug; 34(2):295-304. PubMed ID: 29536266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of New Psychoactive Substances (NPS) in northeast Brazil: NMR-based identification and analysis of ecstasy tablets by GC-MS.
    Cunha RL; Oliveira CDSL; de Oliveira AL; Maldaner AO; do Desterro Cunha S; Pereira PAP
    Forensic Sci Int; 2023 Mar; 344():111597. PubMed ID: 36801502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Aspects of Opium Adulterated with Lead in Iran: A Review.
    Alinejad S; Aaseth J; Abdollahi M; Hassanian-Moghaddam H; Mehrpour O
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):56-64. PubMed ID: 28802093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.